Paradoxical Induction of Psoriasis and Lichen Planus by Tumor Necrosis Factor-α Inhibitors
Related Experiment Video
Updated: Mar 26, 2026
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
1Department of Dermatology, University of Illinois at Chicago College of Medicine, Chicago, IL; sonoaau@gmail.com.
Abstract:
Case 1. A 33-year-old white woman presented to our clinic with a new-onset psoriasiform pustular eruption involving her palms and soles 4 months after the initiation of adalimumab for Crohn's disease. Her medical history was significant for childhood atopic dermatitis and hidradenitis suppurativa, but she had no personal or family history of psoriasis. Topical corticosteroids including hydrocortisone 2.5%, triamcinolone 0.1%, fluocinonide 0.05%, and clobetasol 0.05% were used without improvement. The pustular eruption spread to her scalp, trunk, and proximal extremities, and her toenails developed onycholysis and dystrophy. Her adalimumab was withdrawn for 1 month due to suspicion of a paradoxical pustular psoriasis reaction. After 2 weeks off adalimumab, the pustular dermatosis had significantly diminished and her gastroenterologist changed her medication to methotrexate. Her eruption continued to clear over the course of the next 6 months.
More Related Videos
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Tumor Immunotherapy